Fidicid 200 mg FC tablets.
PDF Leaflet Revision Date: 18 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Clostridium difficile infections (CDI).
Dosage (summary)
200 mg twice daily for 10 days.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Potent P-glycoprotein inhibitors (e.g., ciclosporin, ketoconazole)
Contraindications
- Hypersensitivity to fidaxomicin or excipients
Common side effects
- Vomiting
- Nausea
- Constipation
- Dizziness
Counselling Points
- Take with or without food
- Report any allergic reactions
- May cause dizziness
Serious warnings
- Hypersensitivity reactions including angioedema
- Caution in severe renal or hepatic impairment
Important Disclaimer
The Fidicid 200 mg FC tablets. professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
